(Q51318574)
Statements
Efficacy and safety of the once-weekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients with type 2 diabetes and renal impairment: a randomized phase III study. (English)
1 reference
Lawrence A Leiter
1 reference
Molly C Carr
1 reference
Murray Stewart
1 reference
Angela Jones-Leone
1 reference
Rhona Scott
1 reference
Fred Yang
1 reference
Yehuda Handelsman
1 reference
21 July 2014
1 reference
37
1 reference
10
1 reference
2723-2730
1 reference